SCSoie Chung

Soie Chung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Soie Chung has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metabolic Syndrome and Its Components Are Associated with Closed-Type Endoscopic Atrophic Gastritis in a Large Screening Cohort

    by Sun Young Yang, Huiyeon Kim, Jung Kim, Ji Hyun Song, Jooyoung Lee, Soie Chung, Eun Young Song

    Purpose In recent studies, metabolic syndrome (MetS) has been identified as a risk factor for gastric cancer. To enhance risk stratification protocols and prevention for gastric cancer, we sought to determine whether MetS was associated with atrophic gastritis (AG), the premalignant lesion for gastric cancer. Methods This retrospective cross-sectional study enrolled 12,353 participants who underwent endoscopy during health check-ups between January 2015 and December 2023. Gastric mucosal atrophy was graded according to the Kimura–Takemoto classification. To minimize confounding, propensity score matching was performed using age, sex, smoking status, alcohol consumption, and H. pylori IgG serostatus. Additional analyses were restricted to participants without a history of H. pylori eradication. Results Among participants without prior H. pylori eradication, MetS was significantly associated with closed-type gastric atrophy (C2–C3) (OR 1.153, 95% CI 1.006–1.321, P = 0.041) after propensity score matching. Among the individual MetS components, abdominal obesity, hypertriglyceridemia, low HDL cholesterol, and elevated blood pressure were significantly associated with closed-type atrophy, whereas elevated fasting glucose was not. Similar findings were observed across alternative definitions of gastric atrophy (C2–O3), whereas no significant association was observed for open-type atrophy (O1–O3). Conclusion MetS and several of its components were associated with closed-type gastric atrophy (C2–C3), particularly among individuals without prior H. pylori eradication. These findings suggest that metabolic dysfunction may be associated with moderate atrophic gastric changes and support a potential role of metabolic health in gastric mucosal integrity beyond established H. pylori-related risk factors.

  • Open Access

    Longitudinal Changes in the Serum Pepsinogen I/ II Ratio With Progression of Gastric Atrophy

    by Soie Chung, Jung Kim, Ji Hyun Song, Jooyoung Lee, Sun Young Yang, Eun Young Song

    Background: This study evaluated longitudinal changes in the serum pepsinogen (PG) I/II ratio according to endoscopic gastric mucosal atrophy. Methods: We retrospectively analyzed 21,265 participants who underwent endoscopy during health checkups between 2015 and 2023. Longitudinal changes in PG I/II ratio were examined in 2217 subjects with ≥ 2 endoscopies using linear mixed‐effects models. Serum PG I, PG II, and Helicobacter pylori IgG were measured. The AG severity was graded endoscopically according to Kimura–Takemoto classification. Results: The PG I/II ratio decreased stepwise with advancing Kimura‐Takemoto stage. In longitudinal analyses of 2217 participants with repeated endoscopy, within‐subject declines in the PG I/II ratio paralleled progression of endoscopic atrophy, with greater reductions in more advanced stages (No atrophy: reference; C2: −0.383; C3: −1.150; O1: −1.412; O2: −2.101; O3: −2.007; all p < 0.001). Conclusions: Within‐subject declines in the PG I/II ratio were observed with progression of gastric atrophy. Serial measurement of the PG I/II ratio may be useful for monitoring the progression of gastric mucosal atrophy, particularly in patients for whom repeated endoscopic evaluation is not feasible.

  • Open Access

    Validation of the Martin/Hopkins and Sampson/NIH Equations in Comparison with a Direct Homogeneous Assay in Patients with Hypertriglyceridemia

    by Ji Won In, Jayoun Kim, Soie Chung

    Ji Won In, M.D.,Ph.D, Jayoun Kim, Ph.D, Soie Chung, M.D.. Lab Med Online 2025;15:47-57. https://doi.org/10.47429/lmo.2025.15.1.47


  • Open Access

    Correlation of extended Martin/Hopkins equation with a direct homogeneous assay in assessing low‐density lipoprotein cholesterol in patients with hypertriglyceridemia

    by Soie Chung

    Background: The Friedewald or Martin/Hopkins equation is widely used to estimate low‐density lipoprotein cholesterol (LDL‐C) at triglyceride (TG) levels p < 0.001), demonstrating the EMLDL as the most optimal estimation method, particularly for high TG levels (≥200 mg/dL).Conclusion: Both the original and extended Martin/Hopkins method are optimal in estimating LDL‐C levels in clinical laboratories using the Abbott analyzer in patients with TG levels of 200–399 and 400–799 mg/dL, respectively. Meanwhile, caution is need that considerable underestimation of Friedewald and Sampson equation could lead to undertreatment in hypertriglyceridemia.


  • Open Access

    Association of Plasma Oligomerized Beta Amyloid with Neurocognitive Battery Using Korean Version of Consortium to Establish a Registry for Alzheimer’s Disease in Health Screening Population

    by Jung-Ju Lee, Youngki Choi, Soie Chung, Dae Hyun Yoon, Seung Ho Choi, Sung-Min Kang, David Seo, Kyung-Il Park

    The increasing prevalence of Alzheimer’s disease (AD) has become a global phenomenon presenting serious social and health challenges. For detecting early molecular changes in the disease, several techniques to measure varied species of amyloid beta in the peripheral blood have been recently developed, but the efforts to associate them with cognitive assessments have yet to produce sufficient data. We prospectively collected participants from the consecutive population who visited our center for brain health screening. In total, 97 participants (F:M = 58:39) aged 69.4 ± 7.52 were assessed. Participants performed the Korean version of the Consortium to Establish a Registry for Alzheimer’s disease (CERAD-K), the clinical dementia rating (CDR), plasma oligomeric amyloid-β (OAβ) level tests, routine blood tests, ApoE genotype, and brain MRI. Among total population, 55.7% had a CDR of 0, and 40.2% had a CDR of 0.5. The results showed that word memory and word recall, and the total scores of the CERAD-K were negatively correlated with the plasma OAβ level. With a cut-off value of 0.78 ng/mL for the OAβ level and a −1.5 standard deviation of age/sex/education adjusted norms for the CERAD-K; naming, word memory, word recall, word recognition, and total score were significantly correlated with the OAβ level. No correlation between the OAβ level and mini-mental status examination was found. Our results demonstrate that the level of plasma OAβ was well correlated with the measure of cognitive function through the CERAD-K in the field data collected from consecutive populations. Studies on longitudinal comparisons with large cohorts will further validate the diagnostic value of plasma OAβ as a useful biomarker for screening AD and predicting progression.


  • Update on low-density lipoprotein cholesterol quantification

    by Soie Chung

    Purpose of review: β-Quantification is considered the reference measurement procedure for low-density lipoprotein cholesterol (LDL-C). However, this technique is time-consuming and thus is inappropriate for routine clinical practice. Therefore, the Friedewald equation or homogeneous assays have been widely utilized. As several pitfalls exist with these two methods, a novel method for estimating LDL-C was developed by Martin et al. Recent findings: Martin's method uses a strata-specific median for the triglycerides/very low-density lipoprotein cholesterol (VLDL-C) ratio on the basis of triglycerides and non-HDL-C concentrations. Recent studies show that Martin's method better correlates with β-quantification or homogeneous assays compared with the Friedewald equation, especially with values of triglycerides at least 150 mg/dl and/or LDL-CD less than 70 mg/dl. Such findings have also been demonstrated in other ethnic groups (Japanese and Korean) and disease populations, including diabetes and cardiovascular disease, in which the triglycerides/VLDL-C ratio can be affected. Summary: For the current therapeutic goal of LDL-C values below 70 mg/dl in high-risk patients, accurate assessment of LDL-C levels at very low levels is required. Martin's method could overcome pitfalls such as underestimation of the Friedewald equation at this level. Further evaluation of the triglycerides/VLDL-C ratio in participants with diverse ethnic backgrounds or clinical conditions would expand the implementation of this novel method.


  • GWAS identifying HLA‐DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA‐DPB1*04:02 possessing rs1042169 G ‐ rs9277355 C ‐ rs9277356 A

    by Soie Chung, Eun Youn Roh, Boram Park, Yunhwan Lee, Sue Shin, Jong Hyun Yoon, Eun Young Song

    Recently, HLA class II loci, including HLA‐DPB1, have been reported to be associated with interindividual variance in the hepatitis B (HB) vaccine response. In this study, we investigated significant single nucleotide polymorphisms (SNPs) for anti‐HBs antibody levels in 6867 healthy Koreans using a genome‐wide association study (GWAS). In GWAS, the top 20 SNPs that showed significant association with anti‐HBs levels (P < 1.0 × 10−29) all resided in HLA‐DPB1. Utilizing PCR sequencing, we verified the relationship of the top 3 most significant SNPs (rs1042169, rs9277355 and rs9277356) from the GWAS and genotypes of HLA‐DPB1 with the HB vaccine response in Korean infants who received a scheduled vaccination. The DPB1*04:02 allele has G, C and A nucleotides for the 3SNP sites, and was significantly more frequent in responders than in nonresponders (10.9% vs 1.0%, Pc = 0.018). DPB1*05:01 was significantly more frequent in nonresponders than in responders (49.0% vs 31.1%, Pc = 0.018). In multivariate logistic regression, DPB1*04:02 showed a significant association with both vaccine response (P = 0.037, OR = 8.465) and high‐titre response (P = 0.027, OR = 9.860). The haplotypes rs1042169 G ‐ rs9277355 C ‐ rs9277356 A showed a significant association with a high‐titre response only (P = 0.002, OR = 2.941). In conclusion, DPB1*04:02 possessing rs1042169 G ‐ rs9277355 C ‐ rs9277356 A is an independent predictor of the HB vaccine response in Koreans.


  • Open Access

    HbA1c showed a positive association with carcinoembryonic antigen (CEA) level in only diabetes, not prediabetic or normal individuals

    by Soie Chung, Yunhwan Lee, Eun Youn Roh

    Background: This study was conducted to investigate the association of carcinoembryonic antigen (CEA) and glycated hemoglobin (HbA1c) in normal, prediabetic, and diabetic subjects.Methods: A total of 2,911 participants who underwent general health checkups were enrolled and categorized into the normal, prediabetes, and diabetes groups. Demographic, anthropological, and clinical variables were investigated, and correlations with CEA were analyzed. For 28 diabetic subjects with CEA levels above the upper limit, the follow‐up CEA and HbA1c data were analyzed.Results: Carcinoembryonic antigen levels were significantly different among the normal, prediabetes, and diabetes groups (1.7 ± 1.1 vs 2.0 ± 1.1 vs 2.5 ± 1.5; P < 0.001), and men had higher CEA levels than women in all three groups. Correlation analysis identified a significant positive correlation between serum CEA and HbA1c in the diabetes group using unadjusted and adjusted models (r = 0.189, P < 0.001 and r = 0.218, P < 0.001), and multiple linear regression analysis also revealed that HbA1c was independently and positively correlated with CEA in the diabetes group (β = 0.275, P < 0.001). However, these relationships were inconsistent in the normal and prediabetes groups. The changes in CEA and HbA1c from baseline to follow‐up (delta CEA and delta HbA1c) showed a significant positive correlation (P = 0.021).Conclusions: In diabetes, the CEA level was independently and positively correlated with glycemic control status. Additionally, the change in CEA level (delta CEA) showed a positive correlation with the change in HbA1c level (delta HbA1c) in the follow‐up data analysis.